You are here

  • Home
  • Online First
  • Targeting MYC effector functions in pancreatic cancer by inhibiting the ATPase RUVBL1/2

Article info

Article menu

Download PDFPDF

Pancreas
Original research
Targeting MYC effector functions in pancreatic cancer by inhibiting the ATPase RUVBL1/2

Authors

  • Markus Vogt Cancer Systems Biology Group, Chair of Biochemistry and Molecular Biology, Theodor Boveri Institute, University of Würzburg, Würzburg, GermanyInstitute of Biochemistry, University of Kiel, Kiel, Germany PubMed articlesGoogle scholar articles
  • Nevenka Dudvarski Stankovic Cancer Systems Biology Group, Chair of Biochemistry and Molecular Biology, Theodor Boveri Institute, University of Würzburg, Würzburg, GermanyInstitute of Biochemistry, University of Kiel, Kiel, Germany PubMed articlesGoogle scholar articles
  • Yiliam Cruz Garcia Cancer Systems Biology Group, Chair of Biochemistry and Molecular Biology, Theodor Boveri Institute, University of Würzburg, Würzburg, GermanyInstitute of Biochemistry, University of Kiel, Kiel, Germany PubMed articlesGoogle scholar articles
  • Julia Hofstetter Cancer Systems Biology Group, Chair of Biochemistry and Molecular Biology, Theodor Boveri Institute, University of Würzburg, Würzburg, Germany PubMed articlesGoogle scholar articles
  • Katharina Schneider Cancer Systems Biology Group, Chair of Biochemistry and Molecular Biology, Theodor Boveri Institute, University of Würzburg, Würzburg, GermanyInstitute of Biochemistry, University of Kiel, Kiel, GermanyDepartment of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA PubMed articlesGoogle scholar articles
  • Filiz Kuybu Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA PubMed articlesGoogle scholar articles
  • Theresa Hauck Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA PubMed articlesGoogle scholar articles
  • Bikash Adhikari Cancer Systems Biology Group, Chair of Biochemistry and Molecular Biology, Theodor Boveri Institute, University of Würzburg, Würzburg, GermanyInstitute of Biochemistry, University of Kiel, Kiel, Germany PubMed articlesGoogle scholar articles
  • Anton Hamann Institute for Pharmaceutical Chemistry, Goethe-University Frankfurt, Frankfurt am Main, Germany PubMed articlesGoogle scholar articles
  • Yamila Rocca Max Planck Research Group and Institute of Systems Immunology, University of Würzburg, Würzburg, Germany PubMed articlesGoogle scholar articles
  • Lara Grysczyk Cancer Systems Biology Group, Chair of Biochemistry and Molecular Biology, Theodor Boveri Institute, University of Würzburg, Würzburg, Germany PubMed articlesGoogle scholar articles
  • Benedikt Martin Cancer Systems Biology Group, Chair of Biochemistry and Molecular Biology, Theodor Boveri Institute, University of Würzburg, Würzburg, Germany PubMed articlesGoogle scholar articles
  • Anneli Gebhardt-Wolf Chair of Biochemistry and Molecular Biology, Theodor Boveri Institute, University of Würzburg, Würzburg, Germany PubMed articlesGoogle scholar articles
  • Armin Wiegering Chair of Biochemistry and Molecular Biology, Theodor Boveri Institute, University of Würzburg, Würzburg, GermanyDepartment of General, Visceral, Transplantation, Vascular and Pediatric Surgery, University Hospital Würzburg, Würzburg, Germany PubMed articlesGoogle scholar articles
  • Markus Diefenbacher Comprehensive Pneumology Center (CPC)/Institute of Lung Health and Immunity (LHI), Helmholtz Munich, Member of the German Center for Lung Research (DZL/CPC-M), Munich, GermanyLudwig-Maximilian-Universität München (LMU), Munich, Germany PubMed articlesGoogle scholar articles
  • Georg Gasteiger Max Planck Research Group and Institute of Systems Immunology, University of Würzburg, Würzburg, Germany PubMed articlesGoogle scholar articles
  • Stefan Knapp Institute for Pharmaceutical Chemistry, Goethe-University Frankfurt, Frankfurt am Main, Germany PubMed articlesGoogle scholar articles
  • Dieter Saur Institute of Translational Cancer Research, TUM School of Medicine and Health, Munich, Germany PubMed articlesGoogle scholar articles
  • Martin Eilers Chair of Biochemistry and Molecular Biology, Theodor Boveri Institute, University of Würzburg, Würzburg, Germany PubMed articlesGoogle scholar articles
  • Mathias Rosenfeldt Institute of Pathology, University of Würzburg, Würzburg, Germany PubMed articlesGoogle scholar articles
  • Florian Erhard Computational Systems Virology and Bioinformatics, Institute for Virology and Immunobiology, University of Würzburg, Würzburg, Germany PubMed articlesGoogle scholar articles
  • Seychelle M Vos Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA PubMed articlesGoogle scholar articles
  • Elmar Wolf Cancer Systems Biology Group, Chair of Biochemistry and Molecular Biology, Theodor Boveri Institute, University of Würzburg, Würzburg, GermanyInstitute of Biochemistry, University of Kiel, Kiel, Germany PubMed articlesGoogle scholar articles
  1. Correspondence to Professor Elmar Wolf, Institute of Biochemistry, University of Kiel, Kiel, Germany; elmar.wolf{at}biochem.uni-kiel.de
View Full Text

Citation

Vogt M, Dudvarski Stankovic N, Cruz Garcia Y, et al
Targeting MYC effector functions in pancreatic cancer by inhibiting the ATPase RUVBL1/2
Gut Published Online First: 31 May 2024. doi: 10.1136/gutjnl-2023-331519

Publication history

  • Received December 5, 2023
  • Accepted May 15, 2024
  • First published May 31, 2024.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.